Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's EBIT?
- Vertex Pharmaceuticals (VRTX) reported EBIT of $1.25B in Q2 2026.
- How has Vertex Pharmaceuticals's EBIT changed year-over-year?
- Vertex Pharmaceuticals's EBIT increased by 8.3% year-over-year, from $1.15B to $1.25B.
- What is the long-term trend for Vertex Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's EBIT has grown at a 10.7% compound annual growth rate (CAGR), from $2.78B to $4.17B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Vertex Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude